HBIO Harvard Bioscience Inc.
IndustryBiotechnology: Laboratory Analytical Instruments
- 81.13 P/E
- 1.39 P/S
- 1.45 P/B
- 0.062 EPS
- 13.42% Cash ROIC
- 1.87 Cash Ratio
- 0 / 0% Dividend
- 179,494.00 Avg. Vol.
- 30.06M Shares
- 156.6M Market Cap.
Harvard Bioscience, Inc. develops, manufactures, and markets apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, universities, and government laboratories in the United States and internationally. The company's products target ADMET testing, and molecular biology and liquid handling application areas. Its ADMET testing products comprise...
Boston Business Journal (blog) - May 15, 2013
Harvard Bioscience CEO Graziano will retire - MSN Money
4-traders (press release) - May 1, 2013
NASDAQ (press release) - Apr 26, 2013
GlobeNewswire (press release) - Apr 30, 2013
Webcast Now Available of Press Conference Discussing Landmark Surgery ... - NASDAQ (press release)
NASDAQ - May 2, 2013
Wall Street Journal- India - Apr 30, 2013
BioNews Texas - May 20, 2013
Reuters - May 2, 2013
Wall Street Journal (press release) - May 8, 2013
Milwaukee Journal Sentinel - Apr 26, 2013